Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 4INDUSTRY 2OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Hydatidiform Mole × Clear all
NCT01653392 2024-03-15

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

Emergent BioSolutions

Completed
98 enrolled

Congenital Abnormalities, Abortion, Spontaneous, Birth Weight, Eclampsia, Fetal Death, Hydatidiform Mole, Obstetric Labor, Premature, Pre-Eclampsia, Pregnancy Complications, Pregnancy, Ectopic, Diabetes, Gestational, Premature Birth, Stillbirth, Maternal Death

NCT00190918 2007-08-09

A Trial for Patients With Gestational Trophoblastic Disease

Eli Lilly and Company

Phase 2 Completed
50 enrolled
Gynecologic

Choriocarcinoma, Hydatidiform Mole, Trophoblastic Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡